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Introduction
Cannabis is a common recreational drug 
among young adults that is used to induce 
euphoria, promote relaxation and enhance 
appetite. There is a recognized correlation 
between cannabis abuse and cyclic episodes 
of nausea, vomiting, and abdominal pain 
(cannabinoid hyperemesis syndrome). 
However, the contribution of such 
symptoms to emergency room visits and 
hospital admissions is not known
Aim/Goal
A one-year, retrospective study was 
conducted on patients who presented to the 
emergency department and were later 
admitted at Abington Hospital-Jefferson 
Health with confirmed cannabis use 
(positive urine drug screen).
A total of 100 patients were included in the study, 60% were 
male, 30.3% were admitted with a primary diagnosis of 
gastrointestinal symptoms (e.g., nausea, vomiting and 
abdominal pain or cannabinoid hyperemesis), 26.3% with 
neurological symptoms (i.e., altered mental status, loss of 
consciousness (LOC) and/or seizures), 23.2% with trauma 
(i.e., fall or car accident), and 6.1% with cardiac issues. 34% of 
our patients had no past medical history. Over 50% had at 
least one psychiatric illness and 38.7% were taking at least one 
or more antipsychotic medications. Subgroup analysis of our 
population admitted with GI symptoms (n=30) revealed 47% 
males, 36% active smokers (vs 34% in total population), 33% 
admit to alcohol use (vs 40% in total), 10% positive for opiates 
(vs 18% in total), 6.7% positive for cocaine (vs 8% in total), 
and 16% are on prescribed narcotics (vs 20.2% total). 27 % of 
these patients were placed on GMF with tele or higher level of 
care such as MICU, SICU, or PCU (vs 51% total) and 13.3% 
received echocardiogram (vs 21.2% total). Interesting results 
were observed when stratifying patients based on age and type 
of controlled substance abuse. Marijuana, opiates, and 
benzodiazepines or barbiturates users were more prevalent in 
patients 27-36 yrs. of age, with 30%, 33%, and 50%, 
respectively. While, cocaine, hallucinogens, and 
amphetamines or methamphetamines users were more 





Our primary outcome was to understand the 
prevalence of gastrointestinal symptoms in 
this patient population. We also studied 
other indices including other recreational 
drug use, the level of care, and comorbid 
psychological illnesses.
For More Information Contact: Hadiatou Barry, MD, MPH
Hadiatou.barry@Jefferson.edu
GI symptoms represent an important presenting feature in 
patients with cannabis abuse likely more than any other 
presenting features. However, patients with predominant GI 
symptoms might require lower level of care and less cardiac 
workup. Additional studies are required to elucidate the 
significance of GI symptoms in this population of patients 
further.
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Graph 1: Presenting Symptoms in patients with 








































Graph 3. Level of cardiovascular care for patients with 
positive UDS for THC presented with GI symptoms 
Graph 2: Demographic criteria for patients with THC 
positive UDS presented with GI symptoms
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